Exane Derivatives’s PLDT PHI Stock Holding History

Exane Derivatives’s Portfolio PHI Stock Details PHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,330	Closed	-$84.2K	–	551
2014 Q4	$84.2K	Buy	+1,330	New	+$88.2K	0.01%	300

Other funds holding PHI

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exane Derivatives's PHI Position: Q1 2015 in Review

Exane Derivatives sold out of PLDT (PHI) in Q1 2015, closing a stake of 1,330 shares — an estimated $84.2K sold.

Exane Derivatives first reported a position in PHI in Q4 2014 and held it in 1 quarter. The position peaked at $84.2K in Q4 2014. 103 funds tracked by Wall St. Rank hold PHI as of Q1 2015.

Exane Derivatives reported no remaining PLDT position as of Q1 2015 after selling out during the quarter.
Exane Derivatives sold 1,330 PLDT shares in Q1 2015, an estimated $84.2K.
Exane Derivatives first reported a position in PLDT in Q4 2014 and held it in 1 quarter.
Exane Derivatives's PLDT position peaked at $84.2K in Q4 2014.
103 funds tracked by Wall St. Rank held PLDT as of Q1 2015.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.